
Blood test for Alzheimer's disease is highly accurate, researchers say
Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - and found the test was 95% accurate in identifying patients with existing cognitive impairment linked to the condition.
The US study involved 509 patients in an outpatient memory clinic in Florida and was published in the medical journal Alzheimer's and Dementia.
The test, which has already been approved by the US regulator, was also 82% accurate for specificity, which means it could rule out people without dementia.
Dr Gregg Day, who led the study, said the test was as good as existing, but more invasive, tests.
He said the next step was to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms.
Scientists say the two proteins, which they have identified in blood plasma, are associated with the buildup of amyloid plaques.
Amyloid protein can be found in our brains, but in Alzheimer's disease, amyloid sticks together and forms abnormal deposits, which are thought to be toxic to brain cells.
Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results "suggest this test is very accurate".
"Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before," he added.
In the UK, the Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research.
1:09
Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029.
Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal."
She said the studies like the Blood Biomarker Challenge are a "crucial part of making diagnosis easier and faster, which will bring us closer to a cure".
"The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK," she added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
Deadly vapor claims fifth Manhattan victim: Doctors list no-go areas... and reveal 'mind-altering' symptoms that mimic flu but can kill in days
New York has recorded a fifth death in a deadly outbreak of Legionnaires' disease - a lung infection spread by toxic water vapor - sparking fears of more victims across the city. The city announced Monday that, since an outbreak in late July, 108 people have been infected with Legionnaire's disease, a type of pneumonia that spreads through bacteria lurking in warm later.


Reuters
an hour ago
- Reuters
US pediatric group breaks with federal policy, recommends COVID-19 vaccines for young children
Aug 19 (Reuters) - The American Academy of Pediatrics on Tuesday recommended that all young children get vaccinated against COVID-19, differing from federal policy that no longer recommends routine COVID vaccination for healthy children. The U.S. pediatric group, in its latest policy document, said all young children aged 6-23 months should receive a COVID-19 vaccine regardless of previous doses or SARS-CoV-2 infection, and recommended vaccination for older children in certain risk groups. The U.S. Centers for Disease Control and Prevention said in May COVID-19 vaccines are now an option for healthy children when parents and doctors agree that it is needed. Prior to the new guidance, the agency routinely recommended updated COVID vaccines for everyone aged six months and older, in line with the advice of its panel of outside experts. "Shared clinical decision-making (involving parents and doctors) can be difficult to implement because it lacks clear guidance and does not emphasize the importance of vaccinating people at high risk of severe disease," the AAP said in a statement. In early July, the AAP and other major medical groups sued Health and Human Services Secretary Robert F. Kennedy Jr. for unilaterally removing routine vaccination recommendations. The rate of COVID-19 hospitalization for children under 2 years is the highest among pediatric age groups, and for children aged 6-23 months, it is comparable to people aged 50-64 years, the group said on Tuesday, citing CDC data. The U.S. Department of Health and Human Services earlier this month said it is reinstating a federal task force for safer childhood vaccines after a 27-year hiatus.


Daily Mail
an hour ago
- Daily Mail
Officials record first case in 30 YEARS of locally acquired mosquito-borne disease
New Jersey health officials reported what could be the first locally acquired case of a deadly mosquito-borne illness in the state in 34 years. Authorities are working to confirm if a malaria case in a Morris County resident, who has not traveled internationally, was contracted in the US. The concern surrounding the New Jersey case stems from the fear that the conditions for local transmission, an infected person, a local mosquito capable of carrying the parasite, and a susceptible public, may be converging to pose a potentially serious public health problem. Malaria is caused by a parasite endemic to tropical and subtropical regions globally, including parts of Africa, South Asia, and South America, and is transmitted through bites from Anopheles mosquitoes. Transmission from mosquitoes to people is a greater public health threat in those regions with warm, humid climates. However, rising temperatures across the US are creating more suitable environments for mosquitoes to thrive, increasing the potential for disease transmission. The New Jersey case indicates that infected mosquitoes are circulating locally. While the overall risk remains low, it is no longer zero. Public health officials are containing the threat, but personal precautions such as bug spray are increasingly necessary. A local malaria outbreak requires a specific sequence of events where a mosquito serves as the bridge between an infected traveler and a new, local person. The traveler likely recently arrived in New Jersey from a country where the parasite is endemic, carrying it into the US, where they were bitten by a local anopheles mosquito that then bit a Morris County resident. Each year, the US records roughly 2,000 travel-related malaria cases, resulting in five to 10 deaths. In New Jersey, about 100 such cases are diagnosed annually from returning travelers who were bitten by a mosquito that carried the parasite. If caught early, malaria can be cured with medication, but it can turn deadly very quickly if left untreated with antimalarial drugs. A 24-hour delay can increase the risk of death by one to five times. The unnamed Morris County, New Jersey resident had not traveled recently, but could have been bitten by a local Anopheles mosquito that picked up the malaria-causing parasite. Malaria spreads exclusively through the bite of an infected Anopheles mosquito. It is impossible to catch it from another person through everyday contact, such as touching or sharing food. Acting New Jersey Health Commissioner Jeff Brown said: 'While risk to the general public is low, it's important to take the necessary precautions to prevent locally acquired malaria in New Jersey. 'The most effective ways are to prevent mosquito bites in the first place and to ensure early diagnosis and treatment of malaria in returning travelers.' Locally acquired malaria is exceedingly rare. In 2024, Florida officials confirmed seven cases of malaria in Sarasota, the first in 20 years, most likely due to the presence of Anopheles mosquitoes and the reintroduction of the disease by travelers. And in 2023, a Texas resident who worked outdoors in Cameron County was diagnosed with malaria, the first locally acquired case there since 1994. That same year, a case of malaria was confirmed in Arkansas, and it was the first locally acquired case in the state in at least 40 years. Malaria causes flu-like symptoms such as fever, chills, and fatigue, appearing seven to 30 days after exposure. While curable with prescription drugs, it is fatal without prompt diagnosis and treatment. Even with treatment, mortality rates remain high, between 15 percent and 20 percent. It is a potentially fatal illness, especially for high-risk individuals, including young children, pregnant women, older adults, and those with a weakened immune system or no spleen. Caused primarily by the Plasmodium falciparum parasite, most common in Africa, malaria can lead to severe complications within hours of the first symptoms. Malaria causes severe illness by destroying red blood cells, a process that can rapidly deplete their numbers and lead to life-threatening anemia. A critical lack of oxygen-carrying cells prevents the body's muscles and organs from functioning properly, resulting in feelings of intense drowsiness, weakness, and faintness. A major killer of children under five in places where malaria is endemic is severe malarial anemia, which frequently demands blood transfusions. The complication drove an estimated 627,000 worldwide malaria deaths in 2020, primarily affecting young children in West Africa. Malaria can also cause severe neurological problems, most commonly cerebral malaria, as a result of infected red blood cells becoming sticky and clogging tiny blood vessels in the brain, blocking oxygen delivery. At the same time, the body's intense immune response damages the protective blood-brain barrier, causing it to leak fluid and leading to brain swelling. Beyond cerebral malaria, the illness can also trigger a range of other neurological complications, even after the initial infection has cleared, including Guillain-Barré syndrome, cerebellar ataxia, and a post-malaria neurological syndrome that can involve confusion, seizures, or psychosis. The CDC has dubbed the mosquito the world's deadliest animal. They spread an array of deadly diseases in addition to malaria, including dengue, West Nile, yellow fever, Zika, chikungunya and lymphatic filariasis, a parasitic infection in which adult worms live and reproduce in the lymphatic system. Their capacity to transmit a wide array of devastating illnesses, such as malaria, dengue, West Nile virus, yellow fever, Zika, and chikungunya, results in millions of global deaths every year.